Alignment Healthcare Inc. (ALHC)
NASDAQ: ALHCHealthcareHealthcare PlansUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 8.25 -3.51%
ALHC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.77B
- P/E (TTM)
- 45.00
- Forward P/E
- 11.36
- EPS (TTM)
- $0.19
- Dividend yield
- None
- 52-week range
- 7.37 – 25.12
- Day range
- 8.26 – 8.79
- Volume / Avg
- 6.56M / 7.63M
- Beta
- —
- Shares outstanding
- 207.44M
- Next earnings
- Oct 29, 2026
52-week range
ALHC stock today
On Oct 7, ALHC ended the session at $8.55, adding $0.18 (2.15%), versus the S&P 500's 0.22% decline. At this level, ALHC sits near the bottom of its 52-week range of $7.37 to $25.12: 66.0% below the high, set on Jul 7, 2026 and 16.0% above the low. ALHC is down 56.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 49.6%.
At 45.0x trailing earnings, Alignment Healthcare trades above the peer-group median of 25.5x. Its forward P/E of 11.4x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Alignment Healthcare's next earnings report is expected on Oct 29, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Alignment Healthcare
Company profileAlignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- CEO
- Mr. John E. Kao
- Headquarters
- Orange, CA
- Employees
- 1,849
- IPO year
- 2021
- Website
- alignmenthealth.com
Analyst forecast
ForecastConsensus (14 analysts)
strong_buy
Avg. price target
$20.54+140.23%
- Strong buy 3
- Buy 9
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Oct 29, 2026
- EPS estimate
- $-0.03
Alignment Healthcare peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PGNYProgyny Inc. | 27.55 | +6.33% | $2.11B | vs ALHC |
| CLOVClover Health Investments Corp. Class A | 4.56 | -0.87% | $2.42B | vs ALHC |
| OSCROscar Health Inc. Class A | 32.91 | +1.76% | $10.16B | vs ALHC |
| MOHMolina Healthcare Inc | 194.82 | -0.18% | $10.17B | vs ALHC |
| CNCCentene Corporation | 64.99 | +0.59% | $32.10B | vs ALHC |
| HUMHumana Inc. | 396.51 | -1.92% | $47.61B | vs ALHC |
| CIThe Cigna Group | 278.51 | +1.51% | $73.59B | vs ALHC |
| ELVElevance Health Inc. | 404.31 | +1.05% | $87.68B | vs ALHC |
Indexes, lists and sector
Appears in lists
Alignment Healthcare stock FAQ
What is Alignment Healthcare's stock price today?
ALHC last traded at $8.55 as of Oct 7, 4:00 PM EDT, up 2.15% on the day. Prices are delayed at least 15 minutes.
When is Alignment Healthcare's next earnings date?
Alignment Healthcare is expected to report earnings on Thursday, October 29, 2026. Analysts expect EPS of $-0.03.
What is ALHC's P/E ratio?
ALHC trades at a trailing P/E ratio of 45.00 and a forward P/E of 11.36, compared with a median of 25.5 for its closest peers.
Who is Alignment Healthcare's CEO?
Mr. John E. Kao is the chief executive officer of Alignment Healthcare Inc., which has about 1,849 employees.
What is the ALHC 52-week high?
The 52-week high for ALHC is $25.12 and the 52-week low is $7.37. The stock is currently 66.0% below its high.